TIAA CREF Investment Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-712,333
Closed -$57.1M 3137
2016
Q4
$57.1M Sell
712,333
-111,887
-14% -$8.88M 0.04% 402
2016
Q3
$65.7K Sell
824,220
-320,760
-28% -$25.9M 0.04% 379
2016
Q2
$89.3M Sell
1,144,980
-287,320
-20% -$20.5M 0.07% 292
2016
Q1
$78.8M Buy
1,432,300
+134,869
+10% +$7.35M 0.06% 318
2015
Q4
$80.1M Sell
1,297,431
-59,775
-4% -$3.77M 0.06% 324
2015
Q3
$85.6M Buy
1,357,206
+154,981
+13% +$11.1M 0.07% 300
2015
Q2
$87.8M Sell
1,202,225
-35,615
-3% -$2.57M 0.06% 317
2015
Q1
$81M Sell
1,237,840
-142,892
-10% -$9.5M 0.06% 353
2014
Q4
$89.8M Sell
1,380,732
-274,819
-17% -$17.7M 0.06% 332
2014
Q3
$99.5M Sell
1,655,551
-583,923
-26% -$38.1M 0.07% 296
2014
Q2
$155M Buy
2,239,474
+194,438
+10% +$12.6M 0.11% 211
2014
Q1
$134M Buy
2,045,036
+435,369
+27% +$28.3M 0.1% 240
2013
Q4
$99.7M Buy
1,609,667
+343,701
+27% +$19.9M 0.07% 293
2013
Q3
$67.9M Buy
1,265,966
+201,781
+19% +$10.4M 0.05% 381
2013
Q2
$48.6M Buy
+1,064,185
New +$46.1M 0.04% 455

Other funds holding STJ

TIAA CREF Investment Management's STJ Position: Q1 2017 in Review

TIAA CREF Investment Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 712,333 shares — an estimated $57.1M sold.

TIAA CREF Investment Management first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $155M in Q2 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • TIAA CREF Investment Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • TIAA CREF Investment Management sold 712,333 St Jude Medical shares in Q1 2017, an estimated $57.1M.
  • TIAA CREF Investment Management first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • TIAA CREF Investment Management's St Jude Medical position peaked at $155M in Q2 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on TIAA CREF Investment Management's 13F filing for Q1 2017, filed 11 May 2017.